Cargando…
Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate
BACKGROUND: Metoprolol, a selective beta-1 blocker, is available in two different salt forms in the market – metoprolol succinate (MS) and metoprolol tartarate (MT). Both the formulations are Food and Drug Administration approved for the treatment of hypertension. Several studies have shown similar...
Autores principales: | Vaidya, Varun, Patel, Pranav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284258/ https://www.ncbi.nlm.nih.gov/pubmed/22359463 http://dx.doi.org/10.2147/CEOR.S27609 |
Ejemplares similares
-
Metoprolol succinate extended release/hydrochlorothiazide combination tablets
por: Hainer, James W, et al.
Publicado: (2007) -
Development of a Scalable Process of Film-Coated bi-Layer Tablet Containing Sustained-Release Metoprolol Succinate and Immediate-Release Amlodipine Besylate
por: Tuyen, Nguyen Thi Linh, et al.
Publicado: (2021) -
Design and characterization of controlled release tablet of metoprolol
por: Singhvi, Gautam, et al.
Publicado: (2012) -
New Spectrophotometric Method for Simultaneous determination of Metoprolol Tartarate and Hydrochlorthiazide in Tablets
por: Gupta, K. R., et al.
Publicado: (2008) -
In Silico Comparison Between Metoprolol Succinate and Bisoprolol on 24-Hour Systolic Blood Pressures
por: Jansson, Sven-Olof, et al.
Publicado: (2014)